ISSN 1004-4140
    CN 11-3017/P

    双期双能量CT定量参数对甲状腺乳头状癌初始复发风险分层的预测效能

    Predictive Efficacy of Dual-phase Dual-energy Computed Tomography Quantitative Parameters for Initial Recurrence Risk Stratification in Papillary Thyroid Carcinoma

    • 摘要: 目的:探讨双期(静脉期、动脉期)双能量CT定量参数对甲状腺乳头状癌(PTC)初始复发风险分层的预测效能。方法:收集本院2022年1月至2025年6月收治的114例PTC患者,根据初始复发风险评估,分为低危组(n=84)与中高危组(n=30),比较两组临床资料、双期双能量CT定量参数,并进行单因素与多因素Logistic回归分析双期双能量CT定量参数与PTC初始复发风险分层的关系,利用R软件构建列线图,通过绘制ROC曲线、校准曲线及临床决策曲线,确定该列线图用于初始复发风险分层的预测效能。结果:中高危组病灶长径、短径较低危组更长,动脉期碘浓度(IC)、动脉期有效原子序数(Zeff)、静脉期标准化IC(NIC)、静脉期标准化Zeff(NZeff)更低;多因素Logistic回归提示:动脉期IC、静脉期NIC、静脉期NZeff属于初始中高复发风险的独立影响因素。联合模型预测初始中高复发风险的AUC为0.923(95%CI:0.851−0.980),灵敏度84.8%,特异度81.8%。Hosmer-Lemeshow检验:\chi^2 =1.414,P=0.994,未检出明显的拟合不良。临床决策曲线确定合理的阈值概率范围为0~0.6,当阈值概率>0.6时净收益会有所下降。结论:双期双能量CT定量参数,即动脉期IC、静脉期NIC、静脉期NZeff构建的联合预测模型能够提高PTC初始复发风险分层的术前预测效能,可为临床制定个体化治疗方案和预后评估提供重要的影像学参考依据。

       

      Abstract: Objective: To observe the predictive efficacy of dual-phase (venous and arterial) dual-energy computed tomography (CT) quantitative parameters for the initial recurrence risk stratification of papillary thyroid carcinoma (PTC). Methods: We enrolled 114 PTC patients who underwent surgery between January 2022 and June 2025. Based on the initial recurrence risk assessment, patients were divided into low-risk (n = 84) and medium-high-risk (n = 30) groups. Clinical data and dual-phase dual-energy CT parameters were compared between the two groups. Univariate and multivariate logistic regression analyses were performed to assess the relationship between dual-phase dual-energy CT quantitative parameters and initial recurrence risk stratification of PTC. A nomogram was constructed using R software, and the predictive efficacy for initial recurrence risk stratification was determined by plotting receiver operating characteristic (ROC), calibration, and clinical decision curves. Results: Compared with the low-risk group, the long and short diameters of the lesions in the medium-high-risk group were longer (P < 0.05), and the iodine concentration (IC) in the arterial phase, effective atomic number (Zeff) in the arterial phase, normalized IC (NIC) in the venous phase, and normalized Zeff (NZeff) in the venous phase were lower. Multivariate logistic regression analysis revealed that arterial-phase IC, venous-phase NIC, and venous-phase NZeff were independent risk factors of intermediate-to-high initial recurrence. The combined model demonstrated an area under the curve (AUC) of 0.923 (95% confidence interval CI: 0.851–0.980), with a sensitivity of 84.8% and specificity of 81.8%. Hosmer-Lemeshow test results revealed \chi^2 = 1.414 and P = 0.994, with no significant fitting issues. The clinical decision curve established a reasonable probability threshold range of 0–0.6. Conclusion: The combined predictive model constructed with quantitative parameters of dual-phase dual-energy CT, specifically arterial-phase IC, venous-phase NIC, and venous-phase NZeff, can enhance the preoperative predictive efficacy for initial recurrence risk stratification in PTC, providing a crucial radiological reference for personalized clinical treatment planning and prognosis assessment.

       

    /

    返回文章
    返回